Zinc downregulates HIF-1α and inhibits its activity in tumor cells in vitro and in vivo.
Zinc downregulates HIF-1α and inhibits its activity in tumor cells in vitro and in vivo.
复制标题
DOI:
10.1371/journal.pone.0015048
复制
发表时间:
2010-12-13
期刊:
影响因子:
3.7
通讯作者:
D'Orazi G
中科院分区:
文献类型:
--
作者:
Nardinocchi L;Pantisano V;Puca R;Porru M;Aiello A;Grasselli A;Leonetti C;Safran M;Rechavi G;Givol D;Farsetti A;D'Orazi G
Hypoxia inducible factor-1α (HIF-1α) is responsible for the majority of HIF-1-induced gene expression changes under hypoxia and for the “angiogenic switch” during tumor progression. HIF-1α is often upregulated in tumors leading to more aggressive tumor growth and chemoresistance, therefore representing an important target for antitumor intervention. We previously reported that zinc downregulated HIF-1α levels. Here, we evaluated the molecular mechanisms of zinc-induced HIF-1α downregulation and whether zinc affected HIF-1α also in vivo. Here we report that zinc downregulated HIF-1α protein levels in human prostate cancer and glioblastoma cells under hypoxia, whether induced or constitutive. Investigations into the molecular mechanisms showed that zinc induced HIF-1α proteasomal degradation that was prevented by treatment with proteasomal inhibitor MG132. HIF-1α downregulation induced by zinc was ineffective in human RCC4 VHL-null renal carcinoma cell line; likewise, the HIF-1αP402/P564A mutant was resistant to zinc treatment. Similarly to HIF-1α, zinc downregulated also hypoxia-induced HIF-2α whereas the HIF-1β subunit remained unchanged. Zinc inhibited HIF-1α recruitment onto VEGF promoter and the zinc-induced suppression of HIF-1-dependent activation of VEGF correlated with reduction of glioblastoma and prostate cancer cell invasiveness in vitro. Finally, zinc administration downregulated HIF-1α levels in vivo, by bioluminescence imaging, and suppressed intratumoral VEGF expression. These findings, by demonstrating that zinc induces HIF-1α proteasomal degradation, indicate that zinc could be useful as an inhibitor of HIF-1α in human tumors to repress important pathways involved in tumor progression, such as those induced by VEGF, MDR1, and Bcl2 target genes, and hopefully potentiate the anticancer therapies.
登录
查看更多内容
影响因子:
56.9
作者:
Jaakkola, P;Mole, DR;Ratcliffe, PJ
通讯作者:
Ratcliffe, PJ
影响因子:
2.2
作者:
FALK, W;GOODWIN, RH;LEONARD, EJ
通讯作者:
LEONARD, EJ
影响因子:
21.3
作者:
Calzado, Marco A.;de la Vega, Laureano;Schmitz, M. Lienhard
通讯作者:
Schmitz, M. Lienhard
DOI:
10.1016/j.bbamcr.2008.10.013
发表时间:
2009-02-01
影响因子:
5.1
作者:
Nardinocchi, Lavinia;Puca, Rosa;D'Orazi, Gabriella
通讯作者:
D'Orazi, Gabriella
影响因子:
4.3
作者:
Nardinocchi, Lavinia;Puca, Rosa;D'Orazi, Gabriella
通讯作者:
D'Orazi, Gabriella